Streetbeat News

Revenues

SEER

Seer (NASDAQ:SEER) reported Q2 2024 GAAP EPS of $(0.35), beating the estimate of $(0.36). However, sales of $3.072M missed the $3.200M estimate and were down 23.35% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:38 pm

SG

Sweetgreen has projected its 2024 revenue to be between $670 million and $680 million, compared to the estimated $674.25 million.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:38 pm

PROF

Profound Medical (NASDAQ:PROF) reported Q2 2024 GAAP EPS of $(0.28), beating the estimate of $(0.30). Sales were $2.233M, surpassing the $2.100M estimate. This represents a 20% improvement in EPS and a 39.39% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:38 pm

PUBM

PubMatic has revised its FY24 revenue guidance to $288M-$282M, which is below the previous estimate of $300.3M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:37 pm

EXAI

RXRX

Exscientia plc (NASDAQ:EXAI) will merge with Recursion Pharmaceuticals Inc. (NASDAQ:RXRX), with Exscientia shareholders receiving 0.7729 Recursion shares for each Exscientia share. The combined entity will be named Recursion, headquartered in Salt Lake City, and will trade on NASDAQ. The merger aims to enhance drug discovery capabilities and expects significant synergies and clinical trial readouts in the next 18 months.

Portfolio Pulse from Vandana Singh

August 08, 2024 | 9:37 pm

VERI

Veritone has provided its revenue guidance for Q3 and FY24. The company expects Q3 revenue to be between $34 million and $35 million, and FY24 revenue to be between $136 million and $142 million.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:37 pm

PUBM

PubMatic has revised its Q3 2024 revenue forecast to $65M-$67M, which is below the previous estimate of $70.123M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:37 pm

MCHX

Marchex projects its Q3 revenue to exceed $12.6 million, indicating a positive outlook for the company's financial performance.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:36 pm

HQI

HireQuest (NASDAQ:HQI) reported Q2 2024 GAAP EPS of $0.15, beating the $0.13 estimate. Sales were $8.680M, surpassing the $8.498M estimate but down 3.45% from last year's $8.990M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:36 pm

TRVN

Trevena (NASDAQ:TRVN) reported Q2 EPS of $(0.23), beating the $(0.40) estimate, and sales of $325K, down from $3.02M YoY.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:35 pm